Skip to main content
Premium Trial:

Request an Annual Quote

Eric Rhodes

ERS Genomics has appointed Eric Rhodes as CEO. He succeeds founder Shaun Foy who has been appointed chairman of the company's board of directors. Rhodes joins ERS from Horizon Discovery where he was responsible for commercializing Horizon's genome editing technologies and overseeing research and development. Before his time at Horizon, he held various positions focused on gene editing technologies, including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo Biosciences. 

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.